Track 2: Disruptive Innovation

With 13 sessions specific to Disruptive Innovation, this track focuses on innovations that drive new markets and value networks in the biopharmaceutical industry. Covering topics from leveraging wearables and new frontiers in pharmaceutical manufacturing, to artificial intelligence in clinical trials, this Core Interest Area will ensure you are up-to-date on the latest clinical, scientific, and medical research topics and applications.

Highlights in Disruptive Innovation

The ways in which artificial intelligence (AI) can impact clinical decision-making and how we design and run clinical trials
How effective or robust is AI
Endpoint structures developed to capture disease status and medical product performance, while still allowing interpretability
The complexity of the microbiome in conducting clinical research and monitoring
The potential of 3D printing and how it can provide personalized medicine within clinical trials and on the market
Sophisticated predictive analytic tools and how they transform product development and supply
Featured Topics in Career Development and Wearables/Mobile Health

DIA recommends this track and associated sessions to professionals involved in: regulatory, clinical operations, safety and pharmacovigilance, medical affairs, and data management.

View Other Tracks